CIBT Appoints New Member to External Advisory Board

September 16, 2004

CIBT School of Business & Technology Corp, a subsidiary of Capital Alliance Group Inc. (TSX.V: CPT) is pleased to announce the appointment of Dr. David Hsu to the External Advisory Board.

Dr. David Hsu is a successful businessman, seasoned executive and entrepreneur, while maintaining his practice as a Medical Doctor.

Dr. Hsu graduated summa cum laude from the Medical School of the University of Hamburg, Germany in December 1967. After medical training in Germany and New York, he moved to Orange County, California where he started his private practice in 1977, specializing in gastroenterology. Dr. Hsu has authored and co-authored fifteen articles in medical journals. He is board certified in Internal Medicine and Gastroenterology. He has served as an associate professor of medicine as a clinical faculty member of the Medical School of the University of California, Irvine, CA since 1980. Dr. Hsu further obtained his Master of Business Administration degree from Pepperdine University of Malibu, CA in 1987.

In addition to his medical practice, Dr. Hsu was one of the founders and former Chairman of Multi-Fineline Electronix, Inc., a NASDAQ-listed company (NASD: MFLX) with a market capitalization of US$214 million and revenue of US$129 million in 2003. MFLX has over 5,000 employees in the United States and China, with worldwide sales and distribution channels and several manufacturing plants in Suzhou, China. Since its inception in 1984, Dr. Hsu has been actively involved in the financial planning, marketing and strategic planning and operations of MFLX, with particular emphasis on the establishment and expansion of its manufacturing operations in China. In June 2004, Multi-Fineline Electronix, Inc. completed a successful listing on the NASDAQ stock market in New York. Upon completion of the listing, Dr. Hsu resigned from the board of directors and continues to serve as Chairman Emeritus.

From 2000 to 2003, Dr. Hsu also served as an independent director of i-Cable, Inc., a NASDAQ (NASD: ICAB) and Hong Kong Exchange-listed telecommunications company. I-Cable is a leading provider of telecommunication services in Hong Kong with a market capitalization of US$661 million and revenue of US$276 million.

Dr. Hsu is also a founding partner and Board Chairman of MedicineNet, Inc. (www.MedicineNet.com), an award-winning Internet-based publisher of medical information, which provides free content in easily understandable terms and language. MedicineNet has teamed with physicians and engineers to develop the company from a four-person start-up to over 50 employees and physician writers. Dr. Hsu served to advise management in matters related to funding, e-commerce, marketing, and web content development. MedicineNet is currently rated as one of the top healthcare websites.

“We are very pleased to welcome Dr. Hsu to our External Advisory Board”, stated Toby Chu, President and CEO of CIBT. “With a vision to expand CIBT’s program offerings to the fields of health care and heath sciences management to China and other parts of Asia, Dr. Hsu’s extensive experience in the medical field coupled with his entrepreneurial spirit and business experience, will be invaluable to our expansion plan in the health care sector.”

About CIBT:

Founded in 1994, CIBT School of Business is a recognized business school in Beijing, China. CIBT operates two campuses in Beijing and three learning centers in other cities in China. CIBT has an academic partnership with Beijing University of Technology and delivers postsecondary business and technology education to students and corporations in China. By cooperating with leading education providers in North America, Europe and Asia, CIBT continually develops advanced curricula to meet the needs of China’s growing economy.

On Behalf of the Board of Directors of CIBT.

Toby Chu
President and C.E.O

THE CANADIAN VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION.

“SAFE HARBOR” STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: THIS NEWS RELEASE CONTAINS FORWARD LOOKING STATEMENTS THAT ARE NOT HISTORICAL FACTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE SET FORTH IN OR IMPLIED HEREIN.

Request Info

Request Info Today!

If you have any general inquiries, please fill out this simple form and someone from our team will get back to you shortly!

Inquire today